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Abstract
Background: Histamine assumes an important role as a major mediator in various
pathologic disorders associated with inflammation and immune reactions. However,
the involvement of histamine in the pathological conditions and symptoms of sepsis
remains entirely unknown. In this study, we establish that histamine is identified as a
contributory mediator to promoting the development of organ injury in sepsis.
Methods: Histidine decarboxylase (HDC) gene knockout (HDC−/−) mice, histamine H1-/
H2-receptor gene-double knockout (H1R
−/−/H2R
−/−) mice, and their littermate wild-type
(WT) C57BL/6J mice underwent cecal ligation and puncture (CLP) or sham operation.
Some WT mice were injected intraperitoneally with d-chlorpheniramine and famotidine
60 min before CLP to block H1- and H2-receptors, respectively.
Results: In mice rendered septic by CLP, tissue histamine levels were elevated in
association with increased HDC expression. Sepsis-induced abnormal cytokine
production and multiple organ injury (lung, liver, and kidney) were significantly
less pronounced in HDC−/− mice as compared with WT controls, and HDC deficiency
had improved survival in sepsis. This benefit corresponded with a significant reduction
in activation levels of the nuclear factor (NF)-κB signaling pathway. H1R−/−/H2R−/− mice
apparently behaved similar to HDC knockout mice in reducing sepsis-related pathological
changes. Pharmacological interventions with H1- and H2-receptor antagonists indicated
that both H1- and H2-receptors were involved in septic lung and liver injury, whereas only
H2-receptors contributed to septic kidney injury.
Conclusions: In the setting of sepsis, histamine, through activation of H1- and H2-
receptors, serves as an aggravating mediator to contribute to the development of
sepsis-driven major end-organ failure.
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Background
Sepsis is a common and potentially life-threatening medical condition in popula-
tions in intensive care units (ICU). Despite advances in overall care of critically
ill patients, sepsis remains the primary cause of death from microbial infections
[1, 2]. The development of a failure of one or more organs, including the lung,
kidney, and liver, poses a major threat to the survival of patients with sepsis. In
accordance with the importance of more timely management of patients with
sepsis or at risk of developing sepsis, sepsis is now defined as life-threatening
organ dysfunction due to a dysregulated host response to infection [3]. The
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pathogenesis of sepsis-induced organ failure has been extensively gleaned from
animal models and human studies [4–6], but the mechanisms underlying the path-
ophysiologic processes that both initiate and promulgate organ dysfunction in
sepsis have not been fully elucidated. A greater understanding of the mechanisms
that underlie the development of organ dysfunction in sepsis may enable us to de-
velop therapies targeted at preventing or limiting molecular events associated with
the progress of fatal organ failure and, hence, leading to improved outcomes.
In a prospective, controlled, clinical study, elevated plasma histamine levels have been
shown to be causally associated with sepsis [7]. In our previous studies, the sustained
elevation of plasma histamine has been shown to be associated with the time-
dependent increase in expression of histidine decarboxylase (HDC), which is the cata-
bolic enzyme of histamine synthesis, in the animals with lipopolysaccharide (LPS)- and
cecal ligation and puncture (CLP)-induced sepsis [8–10]. Furthermore, endotoxemia
may cause superinduction of H1- and H2-receptors in cardiovascular and pulmonary
tissues [8, 9, 11]. Since histamine mediates a wide range of cellular responses, including
allergic and inflammatory reactions, gastric acid secretion, vascular tone and permeabil-
ity, and neurotransmission in the central nervous system [12], the histamine biological
responsiveness may be of special importance in certain pathological aspects suggestive
of histamine release. It would be thus allowable to assume that histamine may play a
contributory role in the development of major organ dysfunction and failure associated
with sepsis.
In the present study, we examined whether genetic and pharmacological inter-
ventions of histamine can provide a change in systemic inflammation and organ
injury in mice with CLP-induced polymicrobial sepsis in order to explore the role
of histamine in the pathophysiology of the septic syndrome. CLP-induced sepsis
is an animal model that has high relevance to humans because it reproduces
many hallmarks of sepsis that occur in patients [13]. We applied HDC gene
knockout (HDC−/−) mice [14], lacking histamine, to investigate the effect of hista-
mine deficiency on the pathophysiology of CLP-induced sepsis. Along with HDC
−/− mice, we also used histamine H1-/H2-receptor gene-double knockout (H1R
−/−/H2R
−/−) mice generated by crossbreeding of H1-receptor null mice and H2-re-
ceptor null mice. Finally, we tested changes in the pathophysiological features of
CLP-induced sepsis by pharmacological antagonism of H1- and H2-receptors.
Methods
Generation of HDC−/− mice and H1R
−/−/H2R
−/− mice
HDC−/− mice were generated according to previously described procedures [14].
H1-receptor gene deficient mice and H2-receptor gene deficient mice were a gift
from Prof. Kazuhiko Yanai, Tohoku University [15, 16], and the progeny of the
colony was maintained. Serially breeding of these two strains generated the
double-knockout line (H1R
−/−/H2R
−/−). Genotyping of the resultant mice was
determined by PCR analysis of DNA extracted from tail samples. HDC−/− mice
and H1R
−/−/H2R
−/− mice were of a genetic background of a C57BL/6 J strain, and
their littermates were used as wild-type (WT) controls. Mice were housed under
specific-pathogen-free conditions.
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Animal model of sepsis
All animal studies were conducted in accordance with the National Institute of Health
Guidelines on the use of laboratory animal and with approval of the Care and Use Com-
mittee of the University of Toyama. The surgical procedure to generate CLP-induced sepsis
was performed as described elsewhere [17–19]. In brief, male mice, 8–10 weeks old, were
anesthetized with 3–4% sevoflurane, and a middle abdominal incision was made. The
cecum was mobilized, ligated, and punctured twice with a 21-gauge needle, allowing expos-
ure of faces, the bowel was repositioned, and the abdomen was closed with sterile suture.
Sham-operated control underwent the same procedure except for ligation and puncture of
the cecum. Some WT mice were injected intraperitoneally with a single dose of d-chlor-
pheniramine (10 mg/kg) and famotidine (20 mg/kg) 60 min before CLP to block H1- and
H2-receptors, respectively. A noninvasive computerized tail-cuff system was used for meas-
uring blood pressure and heart rate in mice [17, 20].
Measurement of histamine
The amount of histamine was determined by the fluorometrical method with o-
phthalaldehyde [21]. The tissues were homogenized in 4–5 volumes of PBS con-
taining 2 M NaCl, lysed using 0.5% Triton X-100, and centrifuged at 12,000×g for
30 min at 4 °C in order to obtain the soluble fraction for histamine assay.
RNA extraction and quantitative real-time PCR
Total RNA was isolated from tissues with Sepazol-RNA I Super G (Nacalai Tesque,
Kyoto, Japan). PrimeScript RT Master Mix (Takara Bio, Ohtsu, Japan) or ReverTra Ace
qPCR RT Master Mix (Toyobo, Osaka, Japan) was used for the reverse transcription
reaction, and real-time PCR analyses were performed using SYBR Premix Ex Taq II (Tli
RNaseH Plus), ROX plus (Takara Bio). Values were normalized to glyceraldehyde-3-
phosphate dehydrogenase (GAPDH) according to the manufacturer’s protocol
(MX3000P real-time PCR system; Agilent Technologies Inc., Santa Clara, CA, USA).
Serum analysis
Blood was collected in serum gel tubes (Sarsted, Nümbrecht, Germany), and serum was
obtained and stored at −80 °C. The quantitative determination of aspartate aminotransferase
(AST), alanine aminotransferase (ALT), blood urea nitrogen (BUN), and creatinine in serum
was made on Hitachi 7180 Biochemistry Automatic Analyzer (Hitachi High-Technologies,
Tokyo, Japan). Interleukin (IL)-1β, IL-6, tumor necrosis factor (TNF)-α, and monocyte
chemotactic protein (MCP)-1 were measured by the use of a commercially available
enzyme-linked immunosorbent assay (ELISA) kit (R&D Systems, Minneapolis, MN, USA),
according to the manufacturer’s instructions. The plate was read on a microplate reader
(Nippon-InterMed, Tokyo, Japan). Assays were performed in duplicate.
Lung wet-to-dry weight ratio
Surgically removed lung tissues were blotted dry and weighed to determine the lung
wet weight. The lung tissues were then wrapped loosely in aluminum foil, placed in a
drying oven overnight, and weighed again for calculation of the wet-to-dry weight ratio
[9, 22].
Hattori et al. Intensive Care Medicine Experimental  (2016) 4:36 Page 3 of 19
Histologic examination
Tissues were fixed by immersion in 10 % buffered formaldehyde overnight, embedded
in paraffin, and cut into 4-μm-thick sections. After deparaffinization, slides were
stained with hematoxylin and eosin by standard methods. All the histological studies
were performed in a blinded fashion. A semiquantitative morphometric analysis of
lung injury was performed by scoring from 0 to 4 (none, light, moderate, severe,
very severe) for the following categories: neutrophil infiltration, pulmonary edema,
and disorganization of lung parenchyma and hemorrhage [17]. A total lung injury
score was calculated by adding the individual scores in every animal and averaging
the total values in each group.
Immunohistochemistry
Tissue sections (4 μm) were rehydrated, and endogenous peroxidases were quenched
with 3% hydrogen peroxide. Slides were then incubated overnight at 4 °C with primary
antibodies for myeloperoxidase (MPO; 1:200 dilution; Abcam, Cambridge, MA, USA),
or neutrophil gelatinase-associated lipocalin (NGAL; 1:2000; Abcam). All sections were
incubated with Histofine® Simple Stain Mouse MAX PO(R) (Nichirei Biosciences,
Tokyo, Japan) including the secondary antibody which is reduced to Fab fragment.
Sections were developed with 3,3’-diaminobenzidine and counterstained with
hematoxylin.
Immunofluorescence staining
The tissue sections were exposed to the fluorescent antibody Alexa Fluor 546-
conjugated anti-mouse IgG (Invitrogen, Carlsbad, CA, USA) after overnight incubation
with the primary antibody according to the method in our previous study with minor
modification [20]. The nucleus was counterstained with Hoechst 33342 dye (Invitro-
gen). Immunofluorescence images were observed under an Olympus BX-51 fluores-
cence microscope (Olympus, Tokyo, Japan) and processed using Adobe Photoshop CC
software (Adobe, San Jose, CA, USA).
Western blot analysis
After being removed and rinsed in sterilized PBS on ice, tissues were homogenized and
then centrifuged at 18,000×g for 10 min at 4 °C, and the resulting supernatants were
collected. When required, nuclear protein extracts from lungs were obtained with a
commercially available nuclear extraction kit (Sigma-Aldrich, St. Louis, MO, USA), as
described in the manufacturer’s manual. The proteins in the supernatant were mea-
sured using BCA Protein Assay Kit (Thermo Fisher Scientific, Rockford, IL, USA).
Immunoblotting was performed as described in our previous reports [19, 23]. Samples
(30–50 μg of protein) were electrophoresed on 10 or 14 % SDS-PAGEs and transferred
to PVDF membrane. For primary antibody incubation (overnight at 4 °C), rabbit poly-
clonal or monoclonal antibodies were used against NGAL (1:1,000; Abcam), IκBα
(1:1,000; Cell Signaling, Danvers, MA, USA), and phospho-IκBα (Ser-32) (1:1,000; Cell
Signaling), whereas a mouse monoclonal antibody was used against nuclear factor
(NF)-κB (1:200; Santa Cruz Biotechnology, Santa Cruz, CA, USA), β-actin (1:5,000;
Wako Pure Chemical, Osaka, Japan), and GAPDH (1:5,000; Wako Pure Chemical) and
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a goat polyclonal antibody against lamin B (1:200; Santa Cruz Biotechnology). Primary
antibody detection was performed with horseradish peroxidase-conjugated secondary
antibodies. Binding of the antibody was detected by an ImmunoStar Zeta (Wako Pure
Chemical), and levels of protein expression were quantitated by a luminoimage LAS-
4000 analyzer (Fuji Film, Tokyo, Japan).
Statistical analysis
Values are expressed as means ± SEM. Statistical assessment of the data was made by
Student’s unpaired t test or ANOVA followed by Tukey’s multiple comparison test
using Prism software (ver. 7; GraphPad Software, San Diego, CA, USA). Differences at
p < 0.05 were considered statistically significant.
Results
Changes in tissue histamine concentrations, HDC expression, and histamine receptor
expression after sepsis induction
We initially ascertained whether tissue histamine synthesis is altered in WT mice after
sepsis induction by CLP. As demonstrated in our previous report [10], CLP-induced
polymicrobial sepsis resulted in an increase in plasma concentrations of histamine in
mice (Additional file 1: Figure S1). Thus, plasma histamine concentrations were signifi-
cantly (p < 0.05) elevated from baseline of 16.1 ± 3.5 ng/mL (n = 4) early after CLP, with
a peak concentration at 3 h (38.9 ± 3.5 ng/mL, n = 4). The basal levels of histamine
highly varied between tissues (lung, 349 ± 87 ng/g; liver, 7.9 ± 2.7 ng/g; kidney, 165 ±
14 ng/g, n = 13 for each). When sepsis was induced by CLP, however, histamine levels
elevated in all tissues in a time-dependent manner (Fig. 1a). In mammalian tissues,
histamine is synthesized from L-histidine by HDC. Real-time PCR analysis showed that
the transcript levels of HDC were transiently but greatly increased in all tissues after
induction of sepsis (Fig. 1b).
Changes in histamine H1- and H2-receptor mRNA expression in the lung, liver, and
kidney tissues of WT mice after sepsis induction were also examined by real-time PCR
(Fig. 1b). In lung tissues, no increase in H1-receptor mRNA expression was observed
after CLP. On the other hand, the mRNA levels were increased more than threefold in
liver and kidney tissues at 6–12 h after CLP when compared with those shown in
controls. Following induction of sepsis by CLP, a significant increase in H2-receptor
mRNA expression was transiently detected in lung and liver tissues. In the kidney,
CLP-induced sepsis resulted in a sustained, significant increase in the transcript level of
H2-receptors.
Sepsis-induced inflammation and organ injury are alleviated in HDC knockout mice
When blood levels of proinflammatory or chemotactic cytokines were measured using
an ELISA, the sham-operated control animals had low levels of the cytokines examined
here and no difference was found between WT and HDC−/− mice (Fig. 2a). The animals
18 h after CLP-induced sepsis had marked elevations in IL-1β, IL-6, TNF-α, and MCP-
1. Following sepsis induction, however, HDC−/− mice displayed an evidently lower
levels of those cytokines compared with WT mice. We also examined changes in
mRNA levels of IL-1β, IL-6, TNF-α, and MCP-1 in lung, liver, and kidney tissues using
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real-time PCR (Fig. 2b). After induction of sepsis, mRNA expression levels of those
cytokines greatly increased in all tissues.
The animals subjected to CLP showed a sharp fall in systolic blood pressure (Fig. 3a).
No significant difference in hypotension was observed between WT and HDC−/− mice
after CLP. The CLP-induced sepsis caused a transient decrease in the heart rate in both
Fig. 1 Changes in histamine synthesis and histamine receptor expression in lung, liver, and kidney tissues
from mice after CLP-induced sepsis. a Tissue histamine concentrations after CLP (n = 8/group). b Tissue mRNA
levels of HDC, histamine H1- and H2-receptors after CLP (n = 6/group). The mRNA levels were quantified by real-
time PCR. The values were expressed as a fold increase above control normalized GAPDH. All values are provided
as means ± SEM. *P< 0.05, **P < 0.01, and ***P < 0.001 vs. control
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WT and HDC−/− mice, but the heart rate responses of the two animal groups were not
substantially different (Fig. 3b). HDC−/− mice had a survival advantage after CLP as
compared with WT controls (Fig. 3c).
Histologic examination of hematoxylin and eosin-stained sections of the lungs
showed massive infiltration of inflammatory cells, disorganized architecture with
irregular alveoli, and intra-alveolar hemorrhage arising from capillary rupture in WT
mice 24 h after sepsis induction by CLP (Fig. 4a). In lungs from HDC−/− mice, these
histopathological changes were lessened. Semiquantitative assessment using lung injury
score revealed that the score was significantly lower in HDC−/− mice than in WT
controls. The sepsis-induced increase in lung staining of MPO, an index of neutrophil
infiltration, was significantly reduced in HDC−/− mice in comparison with WT controls
(Fig. 4b). When the wet-to-dry lung weight ratio was measured for assessment of lung
Fig. 2 Reduced cytokine levels in HDC−/− mice following CLP-induced sepsis. a Blood levels of IL-1β, IL-6,
TNF-α, and MCP-1. The blood was collected 18 h after surgery (n = 4–9/group), and those cytokine levels
were measured by the use of ELISA. b Transcription levels of IL-1β, IL-6, TNF-α, and MCP-1 in lung, liver, and
kidney tissues. Tissues were harvested 18 h after surgery (n = 4–11/group). The mRNA levels were quantified
by real-time PCR. The values were expressed as a fold increase above sham-operated control normalized
GAPDH. All values are provided as means ± SEM. *P < 0.05, **P < 0.01, and ***P < 0.001 vs. the respective
control (18 h after sham operation). #P < 0.05 vs. CLP WT
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vascular leak, the ratio was significantly increased in WT mice after sepsis induction
(Fig. 4c).
Following induction of sepsis by CLP, a marked elevation in serum levels of AST and
ALT, a functional readout for liver damage, was observed in WT mice (Fig. 5a). The
elevation in these serum aminotransferase levels after sepsis was significantly lowered
in HDC−/− mice. When liver injury was assessed using liver specimens stained with
hematoxylin and eosin, massive alterations in hepatocytes, including irregular contour
of cells and nuclei, cytoplasmic vacuolation, cytoplasmic and nuclear degeneration, and
cellular rupture, were found in WT mice after sepsis induction (Fig. 5b). A destruction
of the sinusoidal structure of the liver and erythrocyte agglutination were also observed.
Such histopathological alterations showing the liver damage after sepsis was less pro-
nounced in HDC−/− mice. Furthermore, the highly increased neutrophilic influx in the
liver from septic WT mice was indicated by MPO staining (Fig. 5c). There was much
lower MPO expression in liver specimens from HDC−/− mice.
The serum levels of BUN and creatinine, both of which provide a guide to kidney
function, were markedly elevated in septic WT mice (Fig. 6a, b). Pathologically elevated
Fig. 3 Hypotension, heart rate, and mortality in WT and HDC−/− mice with CLP-induced sepsis. a Systolic arterial
blood pressure (SBP) after surgery. b Heart rate changes after surgery. All values are provided as means ± SEM.
*p < 0.05, **p < 0.01; n = 3–5 per group. c Kaplan-Meier survival curves. Eight mice were used for each group.
*p < 0.05 (log rank test)
Hattori et al. Intensive Care Medicine Experimental  (2016) 4:36 Page 8 of 19
serum BUN and creatinine levels were reduced in HDC−/− mice. No apparent histo-
pathological finding was detectable even in WT mice after sepsis induction when the
renal tissue sections were stained using hematoxylin and eosin (Fig. 6c). However, we
found that septic WT mice displayed the intense staining of NGAL, a biomarker of
kidney damage (Fig. 6d). HDC−/− mice following sepsis induction exhibited weaker
NGAL staining in kidneys. In line with the findings from immunohistochemical assess-
ment of renal NGAL, Western blot analysis showed that a striking rise in renal expres-
sion of NGAL caused by sepsis was more evident in WT as compared with HDC−/−
mice (Fig. 6e).
Fig. 4 Reduced lung injury in HDC−/− mice following CLP-induced sepsis. Lung tissues were harvested from
sham-operated and CLP-induced septic mice 24 h after surgery. a Lung sections stained with hematoxylin
and eosin. Original magnification, ×200. A bar graph shows semiquantitative analysis of lung tissues by lung
injury score, which was performed by scoring from 0–4 as described in Methods. A total lung injury score
was calculated by adding the individual scores in every animal and averaging the total values in each
group (n = 4–10/group). b Sections were stained with antibody against MPO followed by peroxidase
staining. Original magnification, x200 or x400. A bar graph shows the summary of quantitation of
MPO-positive cell counts. The average of MPO-positive cell number in three fields per sample was
calculated (n = 4–10/group). c Wet-to-day ratios of lungs harvested from the animals were determined to
assess pulmonary edema (n= 6/group). The summarized results are presented as means ± SEM. *P< 0.05, **P< 0.01,
and ***P< 0.001 vs. the respective control (24 h after sham operation). ##P< 0.01 vs. CLP WT
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Sepsis-induced NF-κB activation is reduced in HDC knockout mice
We examined whether sepsis-induced activation of the transcription factor NF-κB is
altered in HDC−/− mice. Since the activity of NF-κB is primarily regulated by inter-
action with its inhibitory protein IκBα, phosphorylation and degradation of IκBα in
lung tissues after sepsis induction were monitored by Western blot (Fig. 7a). Induction
of sepsis resulted in greatly increased phosphorylation and degradation of IκBα in lungs
of WT mice. Such changes were diminished in HDC−/− mice. The translocation of NF-
κB p65 into the nucleus was increased in lung nuclear extracts from septic WT mice
(Fig. 7b). In HDC−/− mice, the nuclear translocation of NF-κB p65 was weak. In line
with this finding, nuclear staining for NF-κB p65 was more detectable in WT than in
HDC−/− mice after sepsis induction (Fig. 7c).
Fig. 5 Reduced liver injury in HDC−/− mice following CLP-induced sepsis. a, b Serum levels of AST and ALT.
Blood samples were collected from sham-operated and CLP-induced septic mice 18 h after surgery (n= 4–11/
group). All values are provided as means ± SEM. ***P< 0.001 vs. the respective control (18 h after sham operation).
##P < 0.01 vs. CLP WT. c, d Representative micrographs liver sections stained with hematoxylin and eosin and anti-
MPO antibody followed by peroxidase staining. Original magnification, ×200. Tissues were harvested
from sham-operated and CLP-induced septic mice 24 h after surgery. The same results were obtained
with two other experiments
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−/− mice were rendered septic by CLP, the rise in blood levels of
cytokines, IL-6 and MCP-1, was evidently attenuated in comparison with WT
(Fig. 8a). In addition, H1R
−/−/H2R
−/− mice exhibited lower levels of IL-1β, IL-6, and
MCP-1 mRNAs in lung, liver, and kidney tissues as compared with WT following
sepsis (Additional file 2: Figure S2). The histological derangements of the lungs,
liver, and kidney following CLP-induced sepsis were reduced in H1R
−/−/H2R
−/−
mice (Fig. 8b). When serum ALT in H1R
−/−/H2R
−/− mice was measured as a
marker indicative of liver damage, the markedly increased level after sepsis was
subsided (Fig. 8c). Also, the high levels of serum BUN and creatinine, routine mea-




Fig. 6 Reduced kidney injury in HDC−/− mice following CLP-induced sepsis. a, b Serum levels of BUN and
creatinine. Blood samples were collected from sham-operated and CLP-induced septic mice 18 h after
surgery (n = 4–11/group). All values are provided as means ± SEM. ***P < 0.001 vs. the respective control
(18 h after sham operation). #P < 0.05 and ##P < 0.01 vs. CLP WT. c, d Representative micrographs liver
sections stained with hematoxylin and eosin and anti-NGAL antibody followed by peroxidase staining.
Original magnification, ×200. The same results were obtained with two other experiments. e Western
blot image of NGAL protein expression. GAPDH served as loading control. Shown are representative
blots from three independent experiments in which the same results were obtained. Tissues were
harvested from sham-operated and CLP-induced septic mice 24 h after surgery
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Effects of H1- and H2-receptor antagonists on sepsis-induced inflammation and organ
injury
Mice were injected intraperitoneally with a single dose of d-chlorpheniramine (10 mg/
kg) and famotidine (20 mg/kg) 60 min before CLP to block H1- and H2-receptors,
respectively. The elevated blood levels of IL-6 and MCP-1 after sepsis appeared to be
reduced more by combined treatment with d-chlorpheniramine and famotidine than
with famotidine alone (Fig. 9a). Furthermore, the sepsis-induced increases in tissue
levels of IL-1β, IL-6, and TNF-α mRNAs were lowered when the two blockers were
given together to the animals (Additional file 3: Figure S3).
Fig. 7 Kinetics of NF-κB activation in lungs of HDC−/− mice following CLP-induced sepsis. Lung tissues were
harvested from sham-operated and CLP-induced septic mice 18 h after surgery. a Western blot analysis
using anti-IκBα antibody and anti-phospho-IκBα antibody. β-Actin served as loading control. b Nuclear
proteins were extracted, and then NF-κB p65 was detected by Western blot analysis. Lamin B served
as a nuclear marker. c Immunofluorescent images for NF-κB p65 (red) in lung sections. Nuclei were
counterstained with Hoechst 33342 dye (blue). Original magnification, x400. Shown are representative
blots from two independent experiments in which the same results were obtained
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When CLP-induced septic mice received treatment with d-chlorpheniramine,
famotidine, or both, the histological damage in the lungs was apparently mini-
mized and the increase in MPO-positive cells was blunted by each treatment
(Fig. 9b). In liver histology, d-chlorpheniramine, famotidine, or both showed a
Fig. 8 Reduced tissue injury in H1R
−/−/H2R
−/− mice following CLP-induced sepsis. a Blood levels of IL-6 and
MCP-1. b Representative micrographs of tissue sections stained with hematoxylin and eosin, anti-MPO antibody,
and anti-NGAL antibody. Lung, liver, and kidney tissues were harvested from sham-operated and CLP-induced
septic mice 24 h after surgery. Original magnification, ×200 or ×400. The same results were obtained with two
other experiments. c Serum levels of ALT. d Serum levels of BUN and creatinine. Blood and tissue samples were
taken at 18 h after surgery (n = 5–8). All values are provided as means ± SEM. #p < 0.05 vs. CLP WT
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protective effect on liver damage caused by CLP-induced sepsis (Fig. 9b). The
serum ALT levels, which were markedly increased at 18 h after sepsis induction,
were reduced by treatment with each of d-chlorpheniramine and famotidine
(Fig. 9c). In the kidneys, intense accumulation of immunoreactive NGAL that came
along with sepsis remained unchanged with d-chlorpheniramine, but was attenu-
ated by famotidine alone or combined with d-chlorpheniramine (Fig. 9b). Serum
Fig. 9 Effects of treatment with d-chlorpheniramine and famotidine on elevated blood cytokines and organ
injury following CLP-induced sepsis. a Blood levels of IL-6 and MCP-1. b Representative micrographs of tissue
sections stained with hematoxylin and eosin, anti-MPO antibody, and anti-NGAL antibody. Lung, liver, and kidney
tissues were harvested from sham-operated and CLP-induced septic mice 24 h after surgery. Original
magnification, ×200 or ×400. The same results were obtained with two other experiments. c Serum
levels of ALT. d Serum levels of BUN and creatinine. Blood and tissue samples were taken at 18 h after
surgery (n = 6–10/group). All values are provided as means ± SEM. *p < 0.05, **p < 0.01, ***p < 0.001 vs.
the respective sham control. #p < 0.05, ##p < 0.01 vs. CLP alone
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BUN and creatinine levels showed no difference between septic mice untreated
and treated with d-chlorpheniramine, but famotidine treatment blunted the rise in
the serum markers (Fig. 9c).
Discussion
The specific pathophysiology and molecular basis of sepsis-associated multiple organ failure
is still not fully understood. The updated definition of sepsis and septic shock has unveiled
that organ dysfunction/failure is critical in determining the clinical outcome of sepsis [3].
Here, we provide clear evidence that histamine is identified as an aggravating mediator to
contribute to the development of major end-organ (that is, lung, liver, and kidney) injury in
sepsis.
Circulating levels of histamine were significantly elevated in mice after induction
of polymicrobial sepsis by CLP, as fully demonstrated in our previous report [10].
This elevation in the circulating histamine levels was associated with increased
tissue expression of HDC, an enzyme that only forms histamine in mammals. This
could result in locally elevated levels of histamine concentrations in tissues. Indeed,
we found that histamine levels elevated in the lung, liver, and kidney tissues in a
time-dependent manner. In addition, the upregulation of gene expression levels of
H1- and H2-receptors was observed after sepsis induction but quite varied between
tissues. Taken together, these data shadow a possible role of histamine in the patho-
physiology of sepsis.
Our CLP murine model of sepsis developed lung, liver, and kidney injury, as evidenced
by histological changes, neutrophil filtration index, and biochemical variables. We found
that sepsis-induced multiple organ injury was significantly attenuated in HDC−/− mice.
This suggests that the lack of endogenous histamine could help to reduce sepsis-induced
multiple organ injury. Alternatively, we interpret this finding to assume that histamine
acts as a mediator to promote the development of multiple organ injury in sepsis. The
attenuation of septic organ injury in HDC−/− mice may be partly the result of a reduction
in cytokine production. Sepsis triggers overproduction of a diverse set of proinflammatory
and chemotactic cytokines as demonstrated in this study. Their uncontrolled, exuberant
production can be deleterious to various tissues and can lead to organ injury and dysfunc-
tion [24], although the pathogenesis of multiple organ dysfunction is multifactorial and is
still being explored [25]. In agreement with the present results on cytokines in HDC−/−
mice, LPS-stimulated IL-6 production in liver tissues has been shown to fall to a low level
in HDC−/− mice [26]. Moreover, in vitro experiments have reported that histamine
increases IL-6 production in B cells and glial cells [27], endothelial cells [28], and periph-
eral blood mononuclear cells [29], although there is found to be a report showing that
histamine suppresses LPS-induced gene expression and synthesis of TNF-α in peripheral
blood mononuclear cells mediated by H2-receptors [30].
However, our experiments with the H1-receptor antagonist d-chlorpheniramine
and the H2-receptor antagonist famotidine indicate that the lessening of sepsis-
induced organ injury observed in HDC−/− mice cannot be solely attributed to alter-
ations in proinflammatory and chemotactic cytokine production. These antagonists
were not necessarily effective in reducing some cytokines in blood, such as IL-1β
and IL-6, which is inconsistent with their changes obtained in HDC−/− mice. Yet,
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both d-chlorpheniramine and famotidine were effective in reducing septic lung and
liver injury, whereas famotidine, but not d-chlorpheniramine, mitigated septic
kidney injury. This suggests that, while both H1- and H2-receptors are involved in
lung and liver injury, only H2-receptors contribute to kidney injury in sepsis. The
involvement of histamine via H1-receptors in lung vascular hyperpermeability in
sepsis has been documented [9, 31]. H2-receptors have also been shown to be
involved in the recruitment of neutrophils and protein leaks in LPS-induced acute
lung injury [32]. These adverse effects of histamine mediated by H1- and H2-recep-
tors could be responsible for liver injury in sepsis. In renal ischemia/reperfusion
injury, the beneficial effects of the H2-receptor antagonist ranitidine have been
found to be partly mediated by decreased IL-6 production [33]. Furthermore, it has
been reported that mast cell-deficient mice exhibit attenuated acute kidney injury
with cisplatin which is associated with reduced serum TNF-α levels and reduced
recruitment of leukocytes to the inflamed kidney [34].
The transcription factor NF-κB has been well recognized as a pivotal player in
the pathophysiology of sepsis [35]. NF-κB is involved in regulating the transcription
of many of the immunomodulatory mediators that can participate in the develop-
ment of sepsis-induced organ failure [36]. In a myriad of stimuli, commencing with
endotoxin, IκBα is quickly phosphorylated, ubiquitinated, and degraded, releasing
the NF-κB heterodimer, which then translocates from cytoplasm into nucleus to
mediate the transcription of inflammatory genes. Interestingly, IκBα phosphoryl-
ation and degradation following CLP were impaired in lungs of HDC−/− mice. As a
result, HDC−/− mice displayed low nuclear levels of NF-κB p65 in CLP-induced
sepsis. We interpret these results to indicate that histamine can exert a facilitatory
effect on activation of the NF-κB signaling pathway. Thus, histamine may help to
promote the development of major end-organ injury in sepsis by enhancing NF-κB
activity.
Contrary to the present findings indicative the role of H2-receptor activation in worsening
septic liver injury, a previous report has demonstrated that histamine pretreatment can
ameliorate D-galactosamine/LPS-induced liver injury in WT and H1-receptor knockout
mice, but not H2-receptor knockout mice [37]. Furthermore, histamine through H2-recep-
tors has been documented to protect the liver against alcohol-induced injury in rats [38]. It
is difficult to reconcile these findings at present, but possible reasons for the apparent
discrepancy may include different regulatory mechanisms between systemic vs.
local inflammation and concentration-related differences between endogenous vs.
exogenous histamine.
It is now well established that histamine exerts its biological effects by binding to and
activating four distinct separate receptors: H1-, H2-, H3-, and H4-receptors [12].
Although our experiments with d-chlorpheniramine and famotidine imply that H1- and
H2-receptors are involved in the development of septic organ injury, we cannot entirely
exclude that the lack of activation of H3- and H4-receptors may contribute to reduced
organ injury in HDC−/− mice following sepsis. Interestingly, H4-receptors appear to
play a role in sepsis-associated induction of apoptosis in the key organs [10]. The exact
role of H3- and H4-receptors in the pathophysiology of sepsis awaits further study using
the animals deleted for their genes. It should be noted, however, that H1R
−/−/H2R
−/−
mice displayed lesser degree of sepsis-related organ injuries as seen in HDC−/− mice.
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Clinically, H1-receptor antagonists may be prescribed in perioperative settings,
since many narcotics can induce itching [39]. H2-receptor antagonists are widely
used in critically ill patients to reduce the risk of gastrointestinal bleeding [40, 41].
Intriguingly, a significant risk for hospital-acquired pneumonia has been found for
proton pump inhibitor (PPI) use but not H2-receptor antagonists in hospitalized
patients [42], although the findings of an updated meta-analysis to evaluate the
effects of PPIs vs. H2-receptor antagonists on clinically gastrointestinal bleeding in
critically ill patients have shown no differences between drugs in the risk of pneu-
monia, death, or ICU length of stay [43]. Whether H2-receptor antagonists vs. PPIs,
when used for the prevention of gastrointestinal bleeding in the ICU, can differently
affect the development of sepsis-associated organ failure awaits future clinical trials.
Conclusions
This study sheds light on the new role of histamine in the pathophysiology of sepsis. We
represent the first report that endogenous histamine acting on H1- and H2-receptors is
identified as an aggravating mediator to contribute to the development of major end-
organ (that is, lung, liver, and kidney) injury in sepsis. While our present study suggests
the benefit of their treatment in reducing sepsis disorder and supports that they may be
safe medications in critically ill patients with sepsis, the validity and feasibility of the use
of these histamine receptor antagonists to avoid the development of septic organ injury
warrant further clinical investigations and evaluation.
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